Actividades asistenciales

具有增加的稳定性的包含免疫球蛋白的药物产品
23/01/2026 - 本发明涉及一种药物产品,其包含在含有除氧剂的第二包装内的预装填聚合物注射器中的多克隆免疫球蛋白溶液。
线粒体活化用组合物
23/01/2026 - 提供能够活化代谢的方法。具体而言,提供含有特定成分的线粒体活化用组合物。
PROTEIN POLYMER AND USE THEREOF IN TREATMENT OF SPINOCEREBELLAR ATAXIA DISEASE
22/01/2026 - Provided are a protein polymer and the use thereof in the treatment of spinocerebellar ataxia disease. The protein polymer is obtained by means of stimulating MSCs and then lysing same, followed...
治疗边缘型人格障碍的方法
23/01/2026 - 本文提供了使用KDM1A抑制剂、特别是伐菲德司他治疗边缘型人格障碍的方法。
NR2B 선택적 NMDA 수용체 길항제로서의 벤질리덴아미노구아니딘 유도체 및 그 치료적 적용
08/01/2026 - 본 발명은 NR2B 선택적 NMDA 수용체 길항제로서의 벤질리덴 아미노구아니딘 유도체 및 이의 치료적 적용에 관한 것이다.
이미다조피리딘 또는 이미다조피라진 화합물, 이의 제조 방법, 약학 조성물 및 용도
08/01/2026 - 본 발명은 이미다조피리딘 또는 이미다조피라진 화합물, 이의 제조 방법, 약학 조성물 및 용도를 개시한다. 본 발명은 이미다조피리딘 또는...
PROBIOTIC COMPOSITION COMPRISING VIABLE KLEBSIELLA SP. STRAIN ARO112 AS THE ONLY INGREDIENT OR IN COMBINATION WITH SCFA PRODUCING BACTERIA
22/01/2026 - The invention relates to probiotic compositions comprising viable bacteria of Klebsiella strain ARO112, optionally for use as a therapeutic medicament. Compositions of the invention are provided...
INHIBITORY ANTI-CD93 ANTIBODIES
22/01/2026 - The current disclosure relates agents, such as binding proteins, that bind vascular CD93, wherein binding of said agent to CD93 results in of one or more of i) inhibition of perivascular tumor...
NOVEL COMPOUND FOR INHIBITING NAMPT, AND COMPOSITION INCLUDING SAME
22/01/2026 - The present invention relates to a novel compound for inhibiting nicotinamide phosphoribosyl transferase (NamPT), a composition including the same, and various uses thereof.
N-(5-SUBSTITUTED-[(1,3,4-THIADIAZOLYL) OR (1,3-THIAZOLYL)](SUBSTITUTED)CARBOXAMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF PREPARING THE AMIDE COMPOUNDS AND OF THEIR USE
22/01/2026 - The present application discloses specific compounds of Formula (I) and their use in therapy, in particular, their use as Polymerase Theta (Polθ) inhibitors for the treatment of cancer. The...